Cargando...

Effects of concomitant inactivation of p53 and pRb on response to doxorubicin treatment in breast cancer cell lines

Loss of TP53 and RB1 function have both been linked to poor response to DNA damaging drugs in breast cancer patients. We inactivated TP53 and/or RB1 by siRNA mediated knockdown in breast cancer cell lines varying with respect to ER/PgR and Her-2 status as well as TP53 and RB1 mutation status (MCF-7,...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cell Death Discov
Main Authors: Huun, Johanna, Lønning, Per Eystein, Knappskog, Stian
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2017
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5439126/
https://ncbi.nlm.nih.gov/pubmed/28580174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddiscovery.2017.26
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!